This signature includes LDHA, NSDHL, TP53INP2, FLT1, IRS1, ELOVL7, AGPS, FHL2, MED6, PLIN3, VDAC1, and SULT2B1, most of which were revealed to be correlated with tumor proliferation and progression (39–47). Here, MED6 is linked to neoplasm.